- Home
- ADMA vs BOOT Comparison
ADMA vs BOOT Comparison
Compare ADMA & BOOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- BOOT
- Stock Information
- Founded
- ADMA 2004
- BOOT 1978
- Country
- ADMA United States
- BOOT United States
- Employees
- ADMA N/A
- BOOT N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- BOOT Clothing/Shoe/Accessory Stores
- Sector
- ADMA Health Care
- BOOT Consumer Discretionary
- Exchange
- ADMA Nasdaq
- BOOT Nasdaq
- Market Cap
- ADMA 5.1B
- BOOT 4.8B
- IPO Year
- ADMA N/A
- BOOT 2014
- Fundamental
- Price
- ADMA $19.33
- BOOT $171.03
- Analyst Decision
- ADMA Strong Buy
- BOOT Strong Buy
- Analyst Count
- ADMA 3
- BOOT 13
- Target Price
- ADMA $27.67
- BOOT $187.38
- AVG Volume (30 Days)
- ADMA 2.4M
- BOOT 704.9K
- Earning Date
- ADMA 08-06-2025
- BOOT 07-31-2025
- Dividend Yield
- ADMA N/A
- BOOT N/A
- EPS Growth
- ADMA N/A
- BOOT 29.02
- EPS
- ADMA 0.84
- BOOT 6.36
- Revenue
- ADMA $459,381,000.00
- BOOT $1,991,785,000.00
- Revenue This Year
- ADMA $21.11
- BOOT $14.65
- Revenue Next Year
- ADMA $25.97
- BOOT $12.92
- P/E Ratio
- ADMA $23.13
- BOOT $26.87
- Revenue Growth
- ADMA 62.23
- BOOT 16.70
- 52 Week Low
- ADMA $10.21
- BOOT $86.17
- 52 Week High
- ADMA $25.67
- BOOT $183.60
- Technical
- Relative Strength Index (RSI)
- ADMA 62.08
- BOOT 53.25
- Support Level
- ADMA $16.77
- BOOT $165.83
- Resistance Level
- ADMA $18.41
- BOOT $179.89
- Average True Range (ATR)
- ADMA 0.67
- BOOT 6.22
- MACD
- ADMA 0.26
- BOOT -0.49
- Stochastic Oscillator
- ADMA 96.26
- BOOT 41.23
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.